AnPac Bio-Medical Science Co. Ltd. (NASDAQ:ANPC) finished Wednesday with an addition of $0.01 to close at $0.16, an upside of 7.00 percent. An average of 1,125,160 shares of common stock have been traded in the last five days. There was a fall of -$0.0128 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 1,808,760 shares traded, while the 50-day average volume stands at 3,066,582.
ANPC stock has decreased by -54.93% in the last month. The company shares reached their 1-month lowest point of $0.1300 on 09/19/22. With the stock rallying to its 52-week high on 01/04/22, shares of the company touched a low of $0.13 and a high of $4.01 in 52 weeks. It has reached a new high 2 times so far this year and lost -86.84% or -$1.0595 in price. In spite of this, the price is down -96.00% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
AnPac Bio-Medical Science Co. Ltd. (ANPC) has a trailing price-to-sales (P/S) ratio at 1.83, the price-to-book (PB) ratio at 2.29.
The quick ratio of AnPac Bio-Medical Science Co. Ltd. for the recent quarter was 0.40, and the current ratio was 0.40, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 1.33 for the recent quarter. Its gross profit as reported stood at $1.92 million compared to revenue of $2.82 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, AnPac Bio-Medical Science Co. Ltd.’s return on assets was -150.10%.
From a technical analysis perspective, let’s take a brief look at AnPac Bio-Medical Science Co. Ltd. (ANPC) price momentum. RSI 9-day as of the close on 21 September was 37.42%, suggesting the stock is Neutral, with historical volatility in this time frame at 119.61%.
As of today, ANPC’s price is $0.1524 -7.39% or -$0.0128 from its 5-day moving average. ANPC is currently trading -35.83% lower than its 20-day SMA and -59.88% lower than its 100-day SMA. However, the stock’s current price level is -46.27% below the SMA50 and -88.37% below the SMA200.
The stochastic %K and %D were 14.96% and 10.85%, respectively, and the average true range (ATR) was 0.0385. With the 14-day stochastic at 19.06% and the average true range at 0.0397, the RSI (14) stands at 38.56%. The stock has reached -0.0124 on the 9-day MACD Oscillator while the 14-day reading was at -0.0297.
The consensus rating for AnPac Bio-Medical Science Co. Ltd. (ANPC) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ANPC, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is ANPC’s price target for the next 12 months?
Analysts predict a range of price targets between $8.00 and $8.00, with a median target of $8.00. Taking a look at these predictions, the average price target given by analysts for AnPac Bio-Medical Science Co. Ltd. (ANPC) stock is $8.00.